Resveratrol reduces brain injury after subarachnoid hemorrhage by inhibiting oxidative stress and endoplasmic reticulum stress

被引:37
|
作者
Xie, Yun-Kai [1 ]
Zhou, Xin [1 ,2 ]
Yuan, Hong-Tao [1 ]
Qiu, Jie [1 ]
Xin, Dan-Qing [1 ]
Chu, Xi-Li [1 ]
Wang, Da-Chuan [1 ]
Wang, Zhen [2 ]
机构
[1] Shandong Univ, Sch Basic Med Sci, Dept Physiol, Jinan, Shandong, Peoples R China
[2] Shandong Univ, Shandong Prov Hosp, Dept Spinal Surg, Jinan, Shandong, Peoples R China
基金
中国国家自然科学基金;
关键词
nerve regeneration; resveratrol; oxidative stress; endoplasmic reticulum stress; neuroinflammation; subarachnoid hemorrhage; nuclear factor-erythroid 2-related factor 2; heme oxygenase-1; glucose-regulated protein 78; neural regeneration; NEURONAL APOPTOSIS; RAT-BRAIN; PROTECTS; ANTIOXIDANT; PATHWAY; CELLS; MODEL; NEUROPROTECTION; DYSFUNCTION; ACTIVATOR;
D O I
10.4103/1673-5374.257529
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Previous studies have shown that resveratrol, a bioactive substance found in many plants, can reduce early brain injury after subarachnoid hemorrhage, but how it acts is still unclear. This study explored the mechanism using the experimental subarachnoid hemorrhage rat model established by injecting autologous blood into the cerebellomedullary cistern. Rat models were treated with an intraperitoneal injection of 60 mg/kg resveratrol 2, 6, 24 and 46 hours after injury. At 48 hours after injury, their neurological function was assessed using a modified Garcia score. Brain edema was measured by the wet-dry method. Neuronal apoptosis in the prefrontal cortex was detected by terminal deoxyribonucleotidyl transferase-mediated biotin-16-dUTP nick-end labeling assay. Levels of reactive oxygen species and malondialdehyde in the prefrontal cortex were determined by colorimetry. CHOP, glucose-regulated protein 78, nuclear factor-erythroid 2-related factor 2 and heme oxygenase-1 mRNA expression levels in the prefrontal cortex were measured by reverse transcription polymerase chain reaction. Tumor necrosis factor-alpha content in the prefrontal cortex was detected by enzyme linked immunosorbent assay. Immunohistochemical staining was used to detect the number of positive cells of nuclear factor-erythroid 2-related factor 2, heme oxygenase 1, glucose-regulated protein 78, CHOP and glial fibrillary acidic protein. Western blot assay was utilized to analyze the expression levels of nuclear factor-erythroid 2-related factor 2, heme oxygenase 1, glucose-regulated protein 78 and CHOP protein expression levels in the prefrontal cortex. The results showed that resveratrol treatment markedly alleviated neurological deficits and brain edema in experimental subarachnoid hemorrhage rats, and reduced neuronal apoptosis in the prefrontal cortex. Resveratrol reduced the levels of reactive oxygen species and malondialdehyde, and increased the expression of nuclear factor-erythroid 2-related factor 2, heme oxygenase-1 mRNA and protein in the prefrontal cortex. Resveratrol decreased glucose-regulated protein 78, CHOP mRNA and protein expression and tumor necrosis factor-alpha level. It also activated astrocytes. The results suggest that resveratrol exerted neuroprotective effect on subarachnoid hemorrhage by reducing oxidative damage, endoplasmic reticulum stress and neuroinflammation.
引用
收藏
页码:1734 / 1742
页数:9
相关论文
共 50 条
  • [1] Resveratrol reduces brain injury after subarachnoid hemorrhage by inhibiting oxidative stress and endoplasmic reticulum stress
    Yun-Kai Xie
    Xin Zhou
    Hong-Tao Yuan
    Jie Qiu
    Dan-Qing Xin
    Xi-Li Chu
    Da-Chuan Wang
    Zhen Wang
    NeuralRegenerationResearch, 2019, 14 (10) : 1734 - 1742
  • [2] Naringin alleviates early brain injury after experimental subarachnoid hemorrhage by reducing oxidative stress and inhibiting apoptosis
    Han, Yuwei
    Su, Jingyuan
    Liu, Xiujuan
    Zhao, Yuan
    Wang, Chenchen
    Li, Xiaoming
    BRAIN RESEARCH BULLETIN, 2017, 133 : 42 - 50
  • [3] The Role of Oxidative Stress in Early Brain Injury after Subarachnoid Hemorrhage
    Jelinek, M.
    Jurajda, M.
    Duris, K.
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2020, 2020
  • [4] Geniposide attenuates early brain injury by inhibiting oxidative stress and neurocyte apoptosis after subarachnoid hemorrhage in rats
    Xiao, Xiaolan
    Sun, Shuangxi
    Li, Yingbin
    Cen, Xuecheng
    Wu, Shibiao
    Lu, Aili
    Cai, Jun
    Zhao, Junjie
    Li, Shaoxue
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (07) : 6303 - 6311
  • [5] Inhibition of endoplasmic reticulum stress alleviates secondary injury after traumatic brain injury
    Tan, Hong-Ping
    Guo, Qiang
    Hua, Gang
    Chen, Jun-Xi
    Liang, Jun-Chao
    NEURAL REGENERATION RESEARCH, 2018, 13 (05) : 827 - 836
  • [6] Investigation of the Effects of Piceatannol on Endoplasmic Reticulum Stress on Brain in Rats with Experimental Subarachnoid Hemorrhage
    Ozbey, Berna
    Uzun, Metehan
    NAMIK KEMAL MEDICAL JOURNAL, 2024, 12 (02): : 106 - 114
  • [7] Paeoniflorin attenuates early brain injury through reducing oxidative stress and neuronal apoptosis after subarachnoid hemorrhage in rats
    Wang, Tao
    Xu, Ling
    Gao, Lei
    Zhao, Lin
    Liu, Xin-hong
    Chang, Yan-yan
    Liu, Yun-lin
    METABOLIC BRAIN DISEASE, 2020, 35 (06) : 959 - 970
  • [8] Amelioration of oxidative stress and protection against early brain injury by astaxanthin after experimental subarachnoid hemorrhage
    Zhang, Xiang-Sheng
    Zhang, Xin
    Zhou, Meng-Liang
    Zhou, Xiao-Ming
    Li, Ning
    Li, Wei
    Cong, Zi-Xiang
    Sun, Qing
    Zhuang, Zong
    Wang, Chun-Xi
    Shi, Ji-Xin
    JOURNAL OF NEUROSURGERY, 2014, 121 (01) : 42 - 54
  • [9] Ursolic acid reduces oxidative stress to alleviate early brain injury following experimental subarachnoid hemorrhage
    Zhang, Tingting
    Su, Jingyuan
    Wang, Kaiwen
    Zhu, Tingzhun
    Li, Xiaoming
    NEUROSCIENCE LETTERS, 2014, 579 : 12 - 17
  • [10] Hydrogen gas ameliorates oxidative stress in early brain injury after subarachnoid hemorrhage in rats
    Zhan, Yan
    Chen, Chunhua
    Suzuki, Hidenori
    Hu, Qin
    Zhi, Xinggang
    Zhang, John H.
    CRITICAL CARE MEDICINE, 2012, 40 (04) : 1291 - 1296